Skip to main content

You will need to login before you can apply for a job.

Senior Director, Clinical Pharmacology

Employer
Dyne Therapeutics
Location
Waltham, MA
Start date
Jun 15, 2024

View more

Discipline
Clinical, Clinical Research, Science/R&D, Pharmacology
Required Education
Doctorate/PHD/MD
Position Type
Full time
Hotbed
Genetown

Job Details

Company Overview:

Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD), and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD).

Role Summary:

The Senior Director of Clinical Pharmacology will provide leadership to the Clinical Pharmacology and Pharmacometrics team and be accountable for the overall strategy for determining the PK, PD, and immunogenicity properties of all programs at Dyne Therapeutics. This person will be the company’s subject matter expert (SME)and will be responsible for . This position requires an individual with experience and expertise in matrixed leadership and team management, as they will be expected to lead, develop, and educate through cross-functional teams. This individual should be able to efficiently and effectively synthesize data to produce a clinical pharmacology strategy for the programs at Dyne. . The ideal candidate will have a strong knowledge of best practices in Clinical Pharmacology and Pharmacometrics, extensive experience in designing and executing clinical pharmacology studies, and a demonstrated ability to make data-driven decisions based on preclinical and clinical information. The person will also work very closely with team members in the bioanalytical and biomarker function. As a core member of cross-functional program teams the selected candidate will work in close collaboration with colleagues in discovery, research, clinical development, clinical operations, and project management contributing to multiple IND submissions, initiation of clinical development programs, late-stage development, and interactions with health authorities.

This role is based in Waltham, MA without the possibility of being a remote role.

Primary Responsibilities Include:

  • Lead the Clinical Pharmacology function and strategy, with a vision to create scientifically sound, innovative, and efficient programs that meet regulatory requirements, as well as corporate and R&D program goals, enabling advancement of Dyne programs across all stages of drug development.
  • Lead the Clinical Pharmacology accountability for Dyne portfolio from IND to post-approval, including design and implementation of program specific clinical pharmacology studies, data analysis, internal decision points, and external regulatory interactions.
  • Represent Translational Biomarkers  SME providing expertise and guidance on PK/PD and clinical pharmacology on discovery and program teams.
  • integrate clinical pharmacology knowledge with a broad understanding of and collaboration with related disciplines such as clinical development, biostats, regulatory, nonclinical and research to support and impact development decisions
  • Develop clinical pharmacology plans to support the development and registration of Dyne programs.
  • Be responsible for protocol design of clinical pharmacology trials, study planning, review, data analysis / interpretation, and reporting of individual studies implemented to support clinical pharmacology components of project plans.
  • Determine scope, design, and planning and analysis of pharmacokinetic (PK) and pharmacodynamic (PD) studies, and modeling/simulations required from a drug development and regulatory perspective to take a project from concept to NDA submission.
  • Lead and prepare appropriate documents or sections of clinical protocols, clinical study reports with respect to Clinical Pharmacology studies or data.
  • Author regulatory documents (IND’s, NDA’s, IB’s, etc.) and respond to regulatory inquiries related to DMPK, PK/PD, and clinical pharmacology.
  • Identify and manage consultants and vendors and monitor work with external vendors to ensure compliance with agreed protocols, quality standards and timelines.
  • Review external data, lead analysis, interpretation, and reporting of clinical pharmacokinetic and pharmacodynamic data.
  • Ensure that appropriate PK, PD and PK/PD data analyses (including population PK, PK/PD modeling and simulation) are conducted for each study/program while adhering to timelines and budgets to insure prompt and accurate execution of deliverables from clinical pharmacology studies and programs.
  • Collaborate cross functionally with all relevant areas to support corporate objectives.

Education and Skill Requirements:

  • PhD, PharmD, or equivalent training in pharmacokinetics, pharmaceutical sciences, or related disciplines with at least 10 years of bio/pharmaceutical industry drug development experience in Clinical Pharmacology
  • Strong knowledge of pharmacokinetics and pharmacodynamics principles, immunogenicity, modelling and simulation, Model-Informed Drug Development, ADME Concepts, and regulatory clinical pharmacology requirements to support clinical development and regulatory submission.
  • Demonstrated track record and ability to manage the clinical pharmacology/ pharmacokinetic components of programs in clinical stage of development.
  • Experienced in performing Modeling and Simulation (M&S) in drug development (i.e.. PK/PD, PBPK, mechanistic modeling, population PK)
  • Proficient and experienced in using common PK/PD modeling software packages (i.e., Phoenix WinNonlin, NONMEM, R, SAS, and other similar tools)
  • Experienced in preparing Clinical Pharmacology portions of regulatory documents such as the pre-IND, IND, IB, briefing documents, clinical study reports, CTA, and BLA submission documents.
  • Previous experience in antibody-drug conjugates and/or oligonucleotides is desirable.
  • Ability to innovate dosing strategies in a data-driven manner for this novel class of molecule.
  • Strong interpersonal and relationship building skills with demonstrated experience to lead and influence within a matrixed environment.
  • Ability to work and communicate in an open and clear manner, listening effectively and inviting responses and discussions with internal and external partners.
  • Must be independent and highly motivated, with the ability to multi-task, driving strategy and execution, in a fast-paced collaborative environment.

 

 

#LI-Onsite

The statements contained herein reflect general details as necessary to describe the principles functions for this job, the level of knowledge and skill typically required, and the scope of responsibility, but should not be considered an all-inclusive listing of work requirements.  Individuals may perform other duties as assigned, including work in other functional areas to cover absences or relief, to equalize peak work periods or otherwise balance workload.

This description is not intended to be constructed as an exhaustive list of duties, responsibilities, or requirements for the position. This position may change or assume additional duties at any time.  The employee may be requested to perform different or additional duties as assigned. All Employees are expected to adhere to all company policies and act as a role model for company values.

Dyne Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.

Company

Dyne Therapeutics is a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases. With its proprietary FORCE™ platform, Dyne is developing modern oligonucleotide therapeutics that are designed to overcome limitations in delivery to muscle tissue. Dyne has a broad pipeline for serious muscle diseases, including clinical programs for myotonic dystrophy type 1 (DM1) and Duchenne muscular dystrophy (DMD) and a preclinical program for facioscapulohumeral muscular dystrophy (FSHD). For more information, please visit https://www.dyne-tx.com, and follow us on X and Facebook.

CONNECT

x Facebook YouTube Logo 

Stock Symbol: DYN
Stock Exchange: Nasdaq

Company info
Website
Location
1560 Trapelo Road
Waltham
MA
02451
US

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert